10 New Pharmacokinetics Pathways on PharmGKB

PharmGKB releases ten new PK pathways on the website:

Antidepressants: Amitriptyline and Nortriptyline, Fluvoxamine, and Bupropion

Antipsychotics: Clozapine, Haloperidol and Olanzapine
Antiepileptic: Clobazam

NSAIs: Naproxen

Anti-cancer drug: Dasatinib

Anti-hypertensive drug: Verapamil

         

If you are interested in collaborating to develop these for publication as a PharmGKB summary in Pharmacogenetics and Genomics journal please email feedback@pharmgkb.org